Please login to view this media
- Talk
- UK
BOFAS Research Comparing Ankle Replacements and Ankle Fusions
Description
In this informative presentation, Andrew Goldberg expresses his gratitude for being part of the inaugural virtual meeting amidst the peculiar circumstances of the COVID-19 pandemic. He discusses the remarkable achievement of organizing such a meeting in a short period, and shares insights from the collaborative TARVA study, which involves a large team of surgeons and aims to explore treatment options for ankle arthritis.
Goldberg highlights the intricacies of ankle surgery, particularly the procedures of ankle fusion and replacement, and the significant implications these surgeries can have on patients' quality of life. He explains the importance of national joint registries in gathering data to guide clinical decisions regarding the effectiveness of different interventions.
He emphasizes the necessity of running randomized controlled trials (RCTs) to truly ascertain which treatment option—ankle fusion or replacement—yields better outcomes for patients over 50 years old with end-stage arthritis. The speaker proudly discusses the comprehensive data collected through their study, including patient recruitment efforts, which, despite challenges, resulted in a successful enrollment of 324 participants.
Throughout the talk, Goldberg urges the need for equipoise among clinicians when addressing treatment options for their patients to avoid bias in decision-making. He concludes with an optimistic view of the potential impact of the study's findings, thanking the audience and expressing eagerness to return with concrete results in the future.